Distinct mechanisms of long-term virologic control in two HIV-infected individuals after treatment interruption of anti-retroviral therapy.

Autor: Blazkova J; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Gao F; Department of Medicine, Duke University, Durham, NC, USA.; Jinan University School of Medicine, Guangzhou, China., Marichannegowda MH; Department of Medicine, Duke University, Durham, NC, USA.; Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, USA., Justement JS; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Shi V; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Whitehead EJ; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Schneck RF; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Huiting ED; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Gittens K; Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD, USA., Cottrell M; Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina, Chapel Hill, NC, USA., Benko E; Maple Leaf Medical Clinic, Toronto ON, Canada., Kovacs C; Maple Leaf Medical Clinic, Toronto ON, Canada., Lack J; NIAID Collaborative Bioinformatics Resource, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.; Advanced Biomedical Computational Science, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Sneller MC; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Moir S; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Fauci AS; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Chun TW; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. twchun@nih.gov.

Publikováno v: Nature medicine [Nat Med] 2021 Nov; Vol. 27 (11), pp. 1893-1898. Date of Electronic Publication: 2021 Oct 28.

The impact of analytical treatment interruptions and trial interventions on time to viral re‐suppression in people living with HIV restarting ART in cure‐related clinical studies: a systematic review and meta‐analysis.

Autor: Lee, Ming Jie^1,2 (AUTHOR) minglee@doctors.org.uk, Eason, Miles³ (AUTHOR), Castagna, Antonella⁴ (AUTHOR), Laura, Galli⁵ (AUTHOR), De Scheerder, Marie‐Angelique⁶ (AUTHOR), Riley, James⁷ (AUTHOR), Tebas, Pablo⁷ (AUTHOR), Gunst, Jesper^8,9 (AUTHOR), Søgaard, Ole⁸ (AUTHOR), Florence, Eric^10,11 (AUTHOR), Kroon, Eugene¹² (AUTHOR), De Souza, Mark¹² (AUTHOR), Mothe, Beatriz¹³ (AUTHOR), Caskey, Marina¹⁴ (AUTHOR), Fidler, Sarah¹ (AUTHOR)

Publikováno v: Journal of the International AIDS Society. Aug2024, Vol. 27 Issue 8, p1-17. 17p.

An open-label phase 1 clinical trial of the anti-α 4 β 7 monoclonal antibody vedolizumab in HIV-infected individuals.

Autor: Sneller MC; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD 20892, USA., Clarridge KE; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD 20892, USA., Seamon C; Critical Care Medicine Department, Clinical Center, NIH, Bethesda, MD 20892, USA., Shi V; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD 20892, USA., Zorawski MD; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD 20892, USA., Justement JS; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD 20892, USA., Blazkova J; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD 20892, USA., Huiting ED; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD 20892, USA., Proschan MA; Biostatistics Research Branch, NIAID, NIH, Rockville, MD 20892, USA., Mora JR; Takeda Pharmaceuticals International Co., Cambridge, MA 02139, USA., Shetzline M; Takeda Pharmaceuticals International Co., Cambridge, MA 02139, USA., Moir S; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD 20892, USA., Lane HC; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD 20892, USA., Chun TW; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD 20892, USA. twchun@nih.gov., Fauci AS; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD 20892, USA.

Publikováno v: Science translational medicine [Sci Transl Med] 2019 Sep 11; Vol. 11 (509). Date of Electronic Publication: 2019 Sep 05.

Effect of analytical treatment interruption and reinitiation of antiretroviral therapy on HIV reservoirs and immunologic parameters in infected individuals.

Autor: Clarridge KE; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, Maryland, United States of America., Blazkova J; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, Maryland, United States of America., Einkauf K; Ragon Institute of MGH, MIT, and Harvard, Cambridge, Massachusetts, United States of America., Petrone M; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, Maryland, United States of America., Refsland EW; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, Maryland, United States of America., Justement JS; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, Maryland, United States of America., Shi V; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, Maryland, United States of America., Huiting ED; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, Maryland, United States of America., Seamon CA; Critical Care Medicine Department, Clinical Center, NIH, Bethesda, Maryland, United States of America., Lee GQ; Ragon Institute of MGH, MIT, and Harvard, Cambridge, Massachusetts, United States of America., Yu XG; Ragon Institute of MGH, MIT, and Harvard, Cambridge, Massachusetts, United States of America., Moir S; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, Maryland, United States of America., Sneller MC; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, Maryland, United States of America., Lichterfeld M; Ragon Institute of MGH, MIT, and Harvard, Cambridge, Massachusetts, United States of America.; Infectious Disease Division, Brigham and Women's Hospital, Boston, Massachusetts, United States of America., Chun TW; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, Maryland, United States of America.

Publikováno v: PLoS pathogens [PLoS Pathog] 2018 Jan 11; Vol. 14 (1), pp. e1006792. Date of Electronic Publication: 2018 Jan 11 (Print Publication: 2018).

Anesthesia strategies for elderly patients with craniocerebral injury due to foreign-body penetration in the plateau region: a case report.

Autor: Yongtao Sun, Yang Liu, Peng Liu, Min Zhang, Mengjie Liu, Yuelan Wang

Publikováno v: Frontiers in Medicine; 2024, p01-06, 6p